1. Home
  2. TRUP vs WVE Comparison

TRUP vs WVE Comparison

Compare TRUP & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • WVE
  • Stock Information
  • Founded
  • TRUP 2000
  • WVE 2012
  • Country
  • TRUP United States
  • WVE Singapore
  • Employees
  • TRUP N/A
  • WVE N/A
  • Industry
  • TRUP Medical Specialities
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUP Health Care
  • WVE Health Care
  • Exchange
  • TRUP Nasdaq
  • WVE Nasdaq
  • Market Cap
  • TRUP 1.4B
  • WVE 1.7B
  • IPO Year
  • TRUP 2014
  • WVE 2015
  • Fundamental
  • Price
  • TRUP $32.95
  • WVE $11.13
  • Analyst Decision
  • TRUP Buy
  • WVE Strong Buy
  • Analyst Count
  • TRUP 6
  • WVE 10
  • Target Price
  • TRUP $46.60
  • WVE $21.60
  • AVG Volume (30 Days)
  • TRUP 647.6K
  • WVE 759.9K
  • Earning Date
  • TRUP 02-19-2025
  • WVE 03-05-2025
  • Dividend Yield
  • TRUP N/A
  • WVE N/A
  • EPS Growth
  • TRUP N/A
  • WVE N/A
  • EPS
  • TRUP N/A
  • WVE N/A
  • Revenue
  • TRUP $1,285,684,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • TRUP N/A
  • WVE N/A
  • Revenue Next Year
  • TRUP $7.49
  • WVE $48.58
  • P/E Ratio
  • TRUP N/A
  • WVE N/A
  • Revenue Growth
  • TRUP 15.97
  • WVE N/A
  • 52 Week Low
  • TRUP $19.69
  • WVE $4.25
  • 52 Week High
  • TRUP $57.90
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 22.86
  • WVE 44.53
  • Support Level
  • TRUP $44.26
  • WVE $10.79
  • Resistance Level
  • TRUP $50.66
  • WVE $11.78
  • Average True Range (ATR)
  • TRUP 2.45
  • WVE 0.69
  • MACD
  • TRUP -1.19
  • WVE 0.05
  • Stochastic Oscillator
  • TRUP 1.12
  • WVE 43.95

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: